BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33382691)

  • 21. Origins and spread of novel genetic variants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia.
    Basuki S; Fitriah ; Risamasu PM; Kasmijati ; Ariami P; Riyanto S; Hidayat A; Susilowati D; Iskandar ; Armika B; Budiono ; Dachlan YP; Kanbara H; Uemura H
    Malar J; 2018 Dec; 17(1):475. PubMed ID: 30558597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.
    Kar NP; Chauhan K; Nanda N; Kumar A; Carlton JM; Das A
    Infect Genet Evol; 2016 Jul; 41():47-55. PubMed ID: 26988711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India.
    Lumb V; Das MK; Singh N; Dev V; Wajihullah ; Sharma YD
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5173-80. PubMed ID: 19786603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
    Tessema SK; Kassa M; Kebede A; Mohammed H; Leta GT; Woyessa A; Guma GT; Petros B
    PLoS One; 2015; 10(10):e0126943. PubMed ID: 26431464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
    Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Frequency Mutations in
    Yan H; Feng J; Yin JH; Huang F; Kong XL; Lin KM; Zhang T; Feng XY; Zhou SS; Cao JP; Xia ZG
    Front Cell Infect Microbiol; 2021; 11():673194. PubMed ID: 34568082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
    Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD
    J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism in drug resistance genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium falciparum in some states of India.
    Sharma D; Lather M; Mallick PK; Adak T; Dang AS; Valecha N; Singh OP
    Parasit Vectors; 2015 Sep; 8():471. PubMed ID: 26381498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.
    Matondo SI; Temba GS; Kavishe AA; Kauki JS; Kalinga A; van Zwetselaar M; Reyburn H; Kavishe RA
    Malar J; 2014 Apr; 13():152. PubMed ID: 24751352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.
    Artimovich E; Schneider K; Taylor TE; Kublin JG; Dzinjalamala FK; Escalante AA; Plowe CV; Laufer MK; Takala-Harrison S
    J Infect Dis; 2015 Sep; 212(5):694-701. PubMed ID: 25672905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations.
    Sridaran S; McClintock SK; Syphard LM; Herman KM; Barnwell JW; Udhayakumar V
    Malar J; 2010 Aug; 9():247. PubMed ID: 20799995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
    Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
    Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Origins and spread of pfdhfr mutant alleles in Plasmodium falciparum.
    Mita T
    Acta Trop; 2010 Jun; 114(3):166-70. PubMed ID: 19607799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
    Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
    Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012.
    Juma DW; Omondi AA; Ingasia L; Opot B; Cheruiyot A; Yeda R; Okudo C; Cheruiyot J; Muiruri P; Ngalah B; Chebon LJ; Eyase F; Johnson J; Bulimo WD; Akala HM; Andagalu B; Kamau E
    Malar J; 2014 Jul; 13():250. PubMed ID: 24989984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya.
    Gikunju SW; Agola EL; Ondondo RO; Kinyua J; Kimani F; LaBeaud AD; Malhotra I; King C; Thiong'o K; Mutuku F
    Malar J; 2020 May; 19(1):190. PubMed ID: 32448228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.
    Nkoli Mandoko P; Rouvier F; Matendo Kakina L; Moke Mbongi D; Latour C; Losimba Likwela J; Ngoyi Mumba D; Bi Shamamba SK; Tamfum Muyembe JJ; Muepu Tshilolo L; Parzy D; Sinou V
    J Antimicrob Chemother; 2018 Oct; 73(10):2704-2715. PubMed ID: 30053021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
    Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania.
    Kavishe RA; Kaaya RD; Nag S; Krogsgaard C; Notland JG; Kavishe AA; Ishengoma D; Roper C; Alifrangis M
    Malar J; 2016 Jun; 15():335. PubMed ID: 27339129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire.
    Djaman JA; Mazabraud A; Basco L
    Ann Trop Med Parasitol; 2007 Mar; 101(2):103-12. PubMed ID: 17316496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.